Non-severe Hemophilia Treatment - The Fritsma Factor

Dec 22 2022

George Fritsma

Here is a meta-analysis of concentrate treatment for mild to moderate hemophilia.

Iorio A, Königs C, Reding MT, et al. Prophylaxis use of clotting factor replacement products in people with non-severe haemophilia: A review of the literature. Haemophilia. 2022. doi: 10.1111/hae.14676.

Comments (0)

Bleeding Disorders

No comments here.

Leave a Reply Cancel reply

You must be logged in to post a comment.

George Fritsma is a medical laboratory scientist, educator, and author. George holds faculty appointments with Rutgers University and Michigan State University, and is a member of the International Society on Thrombosis and Hemostasis, American Association of Clinical Chemists, and American Society for Clinical Laboratory Science.

Cheat Sheets from George

Quick Question